72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study

Are New Antiretroviral Treatments Increasing the Risk of Weight Gain?

(2021) Shahini Shah et al.   DRUGS

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

(2021) Shahin Lockman et al.   LANCET

Dolutegravir-associated hyperglycaemia in patients with HIV

(2020) Mohammed Lamorde et al.   Lancet HIV

Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial

(2020) Kenneth Kintu et al.   Lancet HIV

INSTIs and weight gain in pregnancy

(2020) Angela M Bengtson et al.   Lancet HIV

Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial

(2020) Willem D F Venter et al.   Lancet HIV

Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon

(2020) Alexandra Calmy et al.   Lancet HIV

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

(2019) Willem D.F. Venter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dolutegravir-Based or Low-Dose Efavirenz–Based Regimen for the Treatment of HIV-1

(2019)   NEW ENGLAND JOURNAL OF MEDICINE

Does U=U for breastfeeding mothers and infants? Breastfeeding by mothers on effective treatment for HIV infection in high-income settings

(2018) Catriona Waitt et al.   Lancet HIV

Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa

(2017) James Hakim et al.   NEW ENGLAND JOURNAL OF MEDICINE

Delayed initiation of antenatal care and associated factors in Ethiopia: a systematic review and meta-analysis

(2017) Gezahegn Tesfaye et al.   Reproductive Health

Maternal and Breastmilk Viral Load

(2016) Nicole L. Davis et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Innovative approaches for improving maternal and newborn health - A landscape analysis

(2015) Karsten Lunze et al.   BMC Pregnancy and Childbirth

Early Initiation of ARV During Pregnancy to Move towards Virtual Elimination of Mother-to-Child-Transmission of HIV-1 in Yunnan, China

(2015) Kathrine Meyers et al.   PLoS One

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

(2013) Sharon L. Walmsley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Maternal Antiretroviral Therapy for the Prevention of Mother-To-Child Transmission of HIV in Malawi: Maternal and Infant Outcomes Two Years after Delivery

(2013) Marina Giuliano et al.   PLoS One

HIV-1 Reservoirs in Breast Milk and Challenges to Elimination of Breast-Feeding Transmission of HIV-1

(2012) P. Van de Perre et al.   Science Translational Medicine

Development and Inter-Rater Reliability of the Liverpool Adverse Drug Reaction Causality Assessment Tool

(2011) Ruairi M. Gallagher et al.   PLoS One

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

(2009)   LANCET